Khushali Pandit/LinkedIn
May 14, 2026, 06:39
Khushali Pandit: Innovations in Cell Therapy Manufacturing Highlighted at ISCT 2026
Khushali Pandit, Quality Assurance Quality Control Manager at CAR T Cell Therapy Centre at Tata Memorial Hospital, shared a post on LinkedIn:
“Proud to see our work being showcased at the ISCT, International Society for Cell and Gene Therapy Conference2026 – poster presentation and an elevator pitch presentation.
Congratulations to my colleague Naitika Bhavsar for presenting the work on APC-independent iNKT cell expansion strategies, contributing towards scalable and accessible cell therapy approaches.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 18:19Nabil Tabish: The Paradox of Zero – Investigating Extreme VWF Discordance
-
Jun 27, 2026, 18:19Francesco Favruzzo: Can Mechanical Thrombectomy Be Safely Used in Cervical Artery Dissection?
-
Jun 27, 2026, 18:18Vera Ghali: 2026 ASH–ISTH Recommendations on Pediatric VTE Prevention
-
Jun 27, 2026, 18:17Michiel Coppens: A Hemostasis Laboratory – One of the Cornerstones of Our Hemophilia Mission
-
Jun 27, 2026, 18:16Sthanu Subramanian: Dabigatran and Mechanical Heart Valves
-
Jun 27, 2026, 15:50Muhammet Özbilen: The Skin as an Emerging Regulator of Iron Homeostasis
-
Jun 27, 2026, 15:07Anteneh Berhane: Supporting Healthier Pregnancies Through Early Nutrition
-
Jun 27, 2026, 14:35Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
-
Jun 27, 2026, 14:01Abdul Mannan: DOACs in Cancer-Associated VTE – When to Avoid Them, And When LMWH Wins